PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
11-May-2023 Orgenesis provides business update for the first quarter of 2023 and reports continued progress on its POCare strategy Orgenesis
11-May-2023 UCB and Ariceum Therapeutics sign a Strategic Research Collaboration to Discover New Modalities for the Treatment of Immune-related Diseases and Cancer UCB and Ariceum
11-May-2023 Transgene provides business update and Q1 2023 financial position Transgene
11-May-2023 PM Society announces new Industry Council and expands Board PM Society
11-May-2023 Cantourage Group SE generates profit in first quarter of 2023 Cantourage Group SE
11-May-2023 RHÖN-KLINIKUM AG looks back on successful Q1 2023 RHÖN-KLINIKUM Aktiengesellschaft
11-May-2023 Successful capital increase for Biophytis with €2.3 million raised Biophytis
11-May-2023 Eckert & Ziegler with Strong Sales Growth in the First Quarter of 2023 Eckert & Ziegler Strahlen- und Medizintechnik AG
11-May-2023 Medios AG: starts successfully into the 2023 financial year Medios AG
11-May-2023 New stock exchange ticker symbol for DocMorris: DOCM (formerly ROSE) DocMorris AG
11-May-2023 Kinarus Therapeutics signed CHF1.5 million convertible loan agreement with ChaoDian (Hangzhou) Investment Management Kinarus Therapeutics Holding AG
10-May-2023 Biophytis launches a round of fundraising for approximately 2 million euros Biophytis
10-May-2023 iTeos Reports First Quarter 2023 Financial Results and Provides Business Updates iTeos Therapeutics, Inc.
10-May-2023 FIMEA renews Nanoform’s GMP license and Nanoform starts clinical API manufacturing of a blockbuster medicine candidate Nanoform Finland Plc
10-May-2023 Cherwell to launch new portable Biofluorescent Particle Counter at Cleanroom Technology Conference UK Cherwell
10-May-2023 STIMULAN now available in South Africa to treat bacterial infection Biocomposites
10-May-2023 Mainz Biomed Partners with Microba Life Sciences for the Development of PancAlert Mainz BioMed N.V.
10-May-2023 BRIM plans to launch a new funding round to accelerate late-stage clinical trial and initiate a new phase 2 trial for orphan drug BRM424 in the U.S Sciad Newswire
10-May-2023 SYNLAB AG: SYNLAB reports strong start to fiscal year 2023 SYNLAB AG
10-May-2023 PharmaSGP with a significant leap in revenue in Q1 2023 – EBITDA grows by more than 40% PharmaSGP Holding SE